Physician profile
Robin E Moran
NPI 1881905297
$474.27
in general payments reported to CMS, 2019-2025
10 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $13.66 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $109.97 | 2024-2025 | |
| Journey Medical Corporation | $97.33 | 2025 | |
| Smith+Nephew, INC. | $80.53 | 2025 | Grafix Pl |
| Ucb, INC. | $69.22 | 2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $23.69 | 2025 | |
| Novartis Pharmaceuticals Corporation | $23.09 | 2025 | |
| Strata Skin Sciences, INC. | $21.08 | 2025 | Xtrac |
| Lnhc, INC | $18.90 | 2025 | Zelsuvmi |
| Pfizer INC. | $16.62 | 2025 | |
| Galderma Laboratories, L.P. | $13.84 | 2025 | Nemluvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Moran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.